These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 26030192)

  • 21. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
    Hokazono A; Etoh S; Jonoshita Y; Kawahira K; Shimodozono M
    J Hand Ther; 2022; 35(4):507-515. PubMed ID: 33820711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
    Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
    J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tibetan Medicated Bathing Therapy for Patients With Post-stroke Limb Spasticity: A Randomized Controlled Clinical Trial.
    Wang M; Liu S; Peng Z; Zhu Y; Feng X; Gu Y; Sun J; Tang Q; Chen H; Huang X; Hu J; Chen W; Xiang J; Wan C; Fan G; Lu J; Xia W; Lihua Wang ; Steven Y Cheng ; Lu X; Li J
    J Am Med Dir Assoc; 2020 Mar; 21(3):374-380.e4. PubMed ID: 31882240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
    Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
    Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
    J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB; Cozens JA; Chamberlain MA; Bamford JM
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early AbobotulinumtoxinA (Dysport
    Rosales RL; Balcaitiene J; Berard H; Maisonobe P; Goh KJ; Kumthornthip W; Mazlan M; Latif LA; Delos Santos MMD; Chotiyarnwong C; Tanvijit P; Nuez O; Kong KH
    Toxins (Basel); 2018 Jun; 10(7):. PubMed ID: 29933562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.
    Kaňovský P; Elovic EP; Munin MC; Hanschmann A; Pulte I; Althaus M; Hiersemenzel R; Marciniak C
    J Rehabil Med; 2021 Jan; 53(1):jrm00138. PubMed ID: 33112408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
    Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
    Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.